Overview
Status
Active
Registry date
2017-10-11
Share capital
5,000.00 PLN
Registered address
ul. Polanki 25/1, 80-308 Gdańsk, Poland
Electronic delivery address
AE:PL-59254-31269-REDGC-22
Financials
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 118 days late).
- 202526/06/2026
- 202415/07/2025
- 202329/06/2024
- 202213/07/2023
- 202110/11/2022
- 202002/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.00kMedianUSD 96.16kAverageUSD 5.86m
Net profit
This companyUSD 24.11MedianUSD 24.11AverageUSD 1.65m
Operating costs
This companyUSD 980.41MedianUSD 75.14kAverageUSD 3.77m
Assets
This companyUSD 264.82MedianUSD 235.86kAverageUSD 9.95m
Industry
Authorized Representatives
Paweł Jakub Nowicki – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Magdalena Maria Nowickaage 38 | 50 | $675.31 | 50% |
Paweł Jakub Nowickiage 41 | 50 | $675.31 | 50% |
Magdalena Maria Nowicka and Paweł Jakub Nowicki hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Gdańsk |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2018-03-01 | Proof of concept fund for R&D projects in the bio-tech-med field | $1.2M$1,188,465 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Eques Investment Towarzystwo Funduszy InwestycyjnychS.A. | $23,918,192.87 | eitfi.pl | ||
| RSI Aifmsp. z o.o. | $27,242.17 | rocksolidinvestments.pl | ||
| Gepol Financingsp. z o.o. | $17,545.83 | gepol.eu | ||
| Genesis CapitalS.K.A. | $8,840.29 | asi.integra-management.pl | ||
| Capital Equatesp. z o.o. | $4,486.32 | capitalequate.pl | ||
| Tredecim Asset ManagementS.A. | $3,530.39 | tredeciminnovation.pl | ||
| Alternatywna Spółka Inwestycyjna DeweloperskieS.A. | $2,818.21 | asi.deweloperskie.pl | ||
| Wind Holding 2 Asisp. z o.o. | $775.41 | windnet.pl | ||
| SukcesijaS.A. | $137.13 | sukcesija.pl | ||
| Best Towarzystwo Funduszy InwestycyjnychS.A. | – | tfi.best.com.pl |
FAQ
The main business activity of BTM Investments focuses on fund management activities.
The company was registered in the Polish National Court Register (KRS) on October 11, 2017.
The headquarters is located at: ul. Polanki 25, 80-308 Gdańsk.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $902, representing a decrease of 34.5% compared to 2023.
No, in 2024 the company was not profitable, reporting a net loss of $1,151.
The largest operating cost category falls under external services. This category amounted to $2,053 in 2024, representing 100% of all operating expenses.
Last updated: 2026-06-30